寶光實業(00084.HK)預期年度虧損不少於1億港元
格隆匯6月2日丨寶光實業(00084.HK)發佈公吿,集團預期截至2025年3月31日止年度公司權益持有人將錄得不少於HK$100百萬應占綜合虧損,而截至2024年3月31日止年度的綜合溢利淨額為HK$473.2百萬。2024財政年度綜合溢利包括出售一間附屬公司及出售一批鐘錶的收益HK$544.2百萬,若撇除2024年出售收益,集團2024財政年度的虧損淨額為HK$71.0百萬。
預期集團於2025財政年度錄得綜合虧損淨額將高於2024年經調整虧損,主要由於2025年3月31日重新估值投資物業相關的減值損失(非現金)HK$24.7百萬及2025財政年度營業額按年下跌約20%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.